Expansion Opportunity Charter Research recently opened a new location in Orlando, Florida, signaling growth and the need to scale operations, clinical support services, and regional patient recruitment capabilities in a key U.S. market.

Partnership Potential Existing collaboration with Eli Lilly on TRAILBLAZER 3 demonstrates openness to strategic clinical partnerships and sponsor-led trials, presenting a doorway for additional co-development or trial support engagements.

Therapeutic Focus As a research services provider aimed at developing medications and therapies to improve health, Charter Research is positioned to offer site management, patient recruitment, data capture, and trial optimization services across early to late-phase programs.

Financial Scale With estimated annual revenue in the mid-range for specialized CROs and a headcount of 51-200, there is room for scalable service packages, volume pricing, and long-term retainer-like engagements in a growing regional hub.

Tech & Compliance The tech stack includes analytics, HR/payroll, and content delivery tools, suggesting opportunities to offer integrated study tech, EDC/IRT, security-compliant data services, and digital patient engagement solutions aligned with regulated environments.